Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - phytomenadione 10.5mg equivalent to 10.0 mg , with 5 % overage - chewable tablet - 10 mg - active: phytomenadione 10.5mg equivalent to 10.0 mg , with 5 % overage excipient: acacia carmellose sodium ceratonia ethyl vanillin glucose glycerol hard paraffin hydrated silica light liquid paraffin milk powder prepared theobroma purified talc rice starch sucrose   theobroma oil titanium dioxide

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - phytomenadione 10 mg/ml - solution for injection - 10 mg/ml - active: phytomenadione 10 mg/ml

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - phytomenadione 2.1 mg/ml equivalent to 2.0 mg + 5 % overage - solution for injection - 1 mg/0.5ml - active: phytomenadione 2.1 mg/ml equivalent to 2.0 mg + 5 % overage excipient: phenol polyoxyl 35 castor oil propylene glycol water for injection

Singapur - Englisch - HSA (Health Sciences Authority)

roche singapore pte. ltd. - phytomenadione - injection - 10 mg/ml - phytomenadione 10 mg/ml

Namibia - Englisch - Namibia Medicines Regulatory Council

roche products (pty) ltd - phytomenadione - solution for injection - each 0.2ml ampoule contains phytomenadion (vit. k1) 2 mg

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - phytomenadione -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - phytomenadione -

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.91 mg/ml;  ; ergocalciferol 0.5 µg/ml; phytomenadione 15 µg/ml; retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.91 mg/ml   ergocalciferol 0.5 µg/ml phytomenadione 15 µg/ml retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.64 mg/ml;  ; ergocalciferol 1 µg/ml; phytomenadione 20 µg/ml; retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.64 mg/ml   ergocalciferol 1 µg/ml phytomenadione 20 µg/ml retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n infant is indicated in paediatric patients up to 11 years of age as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - retinol palmitate ; ergocalciferol ; dl-alfa-tocoferol ; phytomenadione - concentrate for susp for inf - 10 millilitre - vitamins